SCHEMBL13535269

SCHEMBL13535269

CC(=O)[C@H](CSc1ccccc1)C[C@H](O)CN=[N+]=[N-]

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MTNR1A P48039 4/20 0.41
▸ MTNR1B P49286 4/20 0.41
▸ MMP2 P08253 5/20 0.35
▸ MMP9 P14780 5/20 0.35
▸ MAOA P21397 1/20 0.35
▸ MAOB P27338 1/20 0.35
▸ MMP3 P08254 3/20 0.34
▸ MMP13 P45452 2/20 0.34
▸ CA1 P00915 2/20 0.34
▸ CA2 P00918 2/20 0.34
▸ CA4 P22748 2/20 0.34
▸ CA7 P43166 2/20 0.34
▸ CA9 Q16790 2/20 0.34
▸ MMP1 P03956 2/20 0.34
▸ MMP8 P22894 1/20 0.34
▸ FFAR1 O14842 1/20 0.33
▸ EGFR P00533 1/20 0.33
▸ GPR88 Q9GZN0 1/20 0.31
▸ FCER2 P06734 1/20 0.31
▸ ADAM17 P78536 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13535265 0.81 KDM4E (0.43) —
SCHEMBL13535268 0.80 MTNR1A (0.48) MTNR1AMTNR1BMMP2MMP9MAOA
SCHEMBL15713968 0.72 CYP1A2 (0.53) —
SCHEMBL23190984 0.66 MMP2 (0.56) MTNR1AMTNR1BMMP2MMP9MAOA
SCHEMBL14064539 0.64 TRPA1 (0.41) —
SCHEMBL7367582 0.64 MTNR1A (0.51) MTNR1AMTNR1BMMP2MMP9MAOA
SCHEMBL13659834 0.64 MAOA (0.58) MTNR1AMTNR1BMAOAMAOBCA1
SCHEMBL916141 0.64 MAOA (0.56) MTNR1AMTNR1BMAOAMAOBCA1
SCHEMBL7368245 0.63 MTNR1A (0.59) MTNR1AMTNR1BMMP2MMP9MAOA
SCHEMBL13461656 0.63 ALDH1A1 (0.46) MTNR1AMTNR1BMAOAMAOBFFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7649015-B2 Cellular accumulation of phosphonate analogs of HIV protease inhibitor compounds GILEAD SCIENCES, INC. (US) 2010-01-19 — — US disclosed
Send feedback